No, BPC-157 is not safe for long-term use because controlled human clinical data on safety, dosage, and long-term effects remain limited
A landmark 2018 genomics study found GHK-Cu capable of influencing over 4,000 human genes
Interest in BPC-157 largely comes from research and clinical observations suggesting it may help support: Tendon and ligament repair Muscle recovery after strain or overuse Joint mobility and comfort Reduced inflammation around injured tissues Unlike options that simply dull pain, BPC-157 is often discussed for its potential to support recovery at the tissue level
however, only variable efficacy has been demonstrated in reducing disease activity in SLE patients, possibly due to trial design that cannot preselect those patients that might benefit the most from peptide immunotherapy
If you were to use the entire contents of the vial in a single application, immediately after reconstitution, this would be an acceptable choice
Figures above 900 pg/ml are considered high, but certain cases have recorded four or even five figure values